Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for advanced metabolic pathway research, incretin signaling, and glucose regulation mechanisms. Commonly investigated in laboratory models exploring weight management and insulin sensitivity. For laboratory research use only.